Cargando…
Effectiveness of a combination of cyclosporine A, suplatast tosilate and prednisolone on periodic oscillating hypereosinophilia
We report the treatment course of a 29-year-old man who has had unique oscillating FIP1L1-PDGFRA fusion gene-negative hypereosinophilic syndrome (HES) for nearly 6 years. His periodic oscillating pattern of eosinophilia associated with angioedematous soft tissue swelling has shown two to three seaso...
Autores principales: | Imashuku, Shinsaku, Ueda, Ikuyo, Inaba, Tohru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658243/ https://www.ncbi.nlm.nih.gov/pubmed/23754911 http://dx.doi.org/10.2147/IMCRJ.S26102 |
Ejemplares similares
-
Case of Eosinophilic Cystitis Treated with Suplatast Tosilate as Maintenance Therapy
por: Yoshino, Tateki, et al.
Publicado: (2012) -
Suplatast Tosilate and Eicosapentaenoic Acid as a Possible Strategy for Maintaining Remission in Minimal Change Nephrotic Syndrome: A Case Report
por: Shichijo, Ayako Y, et al.
Publicado: (2023) -
Suppressive effects of anti-allergic agent suplatast tosilate (IPD-1151T) on the expression of co-stimulatory molecules on mouse splenocytes in vivo.
por: Kurokawa, M, et al.
Publicado: (2001) -
The inhibitory effect of anti-allergic agent suplatast tosilate (IPD-1151T) on methacholine- and allergen-induced bronchoconstriction in sensitized mice. asakazu@med.showa-u.dc.jp.
por: Asano, K, et al.
Publicado: (2000) -
Valemetostat Tosilate: First Approval
por: Keam, Susan J.
Publicado: (2022)